RELIABLE BIOPHARMACEUTICAL CORP has a total of 13 patent applications. Its first patent ever was published in 2010. It filed its patents most often in Canada, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and macromolecular chemistry and polymers are SOLUX CORP, BIOSYNTH AS and BALKANFARMA RAZGRAD AD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | India | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Sugars | |
#2 | Medical preparations | |
#3 | Polysaccharides | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nadji Sourena | 8 |
#2 | Ma Chun | 7 |
#3 | Smoot James T | 6 |
#4 | Vanartsdalen Joseph A | 6 |
#5 | Patel Payal Parth | 6 |
#6 | Ohrr Kevin K | 6 |
#7 | Sourena Nadji | 5 |
#8 | Wooldridge Luzviminda T | 1 |
Publication | Filing date | Title |
---|---|---|
WO2012149196A1 | Improved processes for the preparation of regadenoson and a new crystalline form thereof | |
CA2862606A1 | An efficient and scalable process for the manufacture of fondaparinux sodium | |
CN104245718A | Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof |